It looks like Eli Lilly has acquired Ajax Therapeutics, a company whose drug candidate is entering Phase 1.
The total purchase price is $2.3 billion.
It just occurred to me: with those partnership discussions underway and reportedly over ten interested candidates involved, could this eventually turn into an acquisition as well?
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera | Eli Lilly and Company